EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Autoantibodies and Inflammation in Schizophrenia

Hiroki Shiwaku iD

Psychiatry and Clinical Neurosciences · 2025-10 · 79 (10) · 611-618

DOI: 10.1111/pcn.13872 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Psychiatry and Clinical Neurosciences, online erschienen am 22.07.2025. Verfasst von Hiroki Shiwaku. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Schizophrenia, Autoantibodies, Inflammation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fusion Oriented REsearch for disruptive Science and Technology, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The potential role of autoantibodies in the etiology of schizophrenia is a key research focus because growing evidence suggests an association between immune dysfunction and psychotic disorders. This hypothesis is supported by findings indicating immune‐related abnormalities in patients with schizophrenia, including chronic inflammation and genetic alterations associated with immune system dysregulation. Epidemiological studies have reinforced this perspective by demonstrating a significant correlation between autoimmune diseases and schizophrenia, suggesting shared pathological mechanisms including autoantibodies. A particularly compelling line of evidence comes from the identification of autoantibodies targeting synaptic molecules in patients with schizophrenia. Autoantibodies against N‐methyl‐D‐aspartate (NMDA) receptors, gamma‐aminobutyric acid (GABA) receptors, neural cell adhesion molecule 1 (NCAM1), and neurexin 1 (NRXN1) have been detected in patients, raising the possibility that immune‐mediated synaptic dysfunction contributes to the disorder's pathophysiology. Experimental studies support this notion because the administration of these autoantibodies in mice induces molecular, cellular, and behavioral abnormalities that mirror aspects of schizophrenia. This review summarizes the relationships among schizophrenia, inflammation, immune‐related genetic factors, autoimmune diseases, and autoantibodies. Furthermore, this review discusses future research directions for further elucidating the role of autoantibodies in schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaAutoantibodiesInflammationHumansAnimalsReceptors, N-Methyl-D-AspartateAutoimmune Diseases

Stichwörter der Autor:innen

autoantibodiesautoimmunityinflammationschizophrenia

Substanzen

AutoantibodiesReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Institute of Science Tokyo, Tokyo, Japan.

ORCID-Profile: Hiroki Shiwaku

Förderung

  • Fusion Oriented REsearch for disruptive Science and Technology
  • Japan Agency for Medical Research and Development

Zitieren

APA

Shiwaku, H. (2025). Autoantibodies and Inflammation in Schizophrenia. Psychiatry and Clinical Neurosciences, 79(10), 611-618. https://doi.org/10.1111/pcn.13872

Vancouver

Shiwaku H. Autoantibodies and Inflammation in Schizophrenia. Psychiatry and Clinical Neurosciences. 2025;79(10):611-618. doi:10.1111/pcn.13872

BibTeX
@article{Shiwaku2025,
  author = {Shiwaku, Hiroki},
  title = {Autoantibodies and Inflammation in Schizophrenia},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2025},
  volume = {79},
  number = {10},
  pages = {611--618},
  doi = {10.1111/pcn.13872}
}
Kostenlos starten →